Dermatology · Pasadena, MD
NPI
1396714994
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8028 Ritchie Hwy, Suite 110
Pasadena, MD, 21122
Phone (410) 766-0111
Groups this clinician bills Medicare through
Medicare paid, 2024
$220K
4,185 services
Medicare patients, 2024
546
Average age 74
Drug cost, 2024
$269K
1,452 prescriptions
Company payments, 2025
$871
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Allison M Linquist was code 17003 (destruction skin lesion), 1,022 times for 220 patients. In total Allison M Linquist billed 4,185 services in 85 codes, and Medicare paid $220K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,022 | 220 | $4.92 | $5,026 |
| 99214 Office E&M - Established | Office | 630 | 490 | $85.64 | $54K |
| 17000 Destruction Skin Lesion | Office | 393 | 327 | $26.73 | $11K |
| 17110 Destruction Skin Lesion | Office | 342 | 293 | $56.41 | $19K |
| 11301 Removal or Shaving of Skin Growth | Office | 172 | 137 | $59.60 | $10K |
| 10040 Removal or Shaving of Skin Growth | Office | 152 | 134 | $67.51 | $10K |
| 17004 Destruction Skin Lesion | Office | 135 | 95 | $124.73 | $17K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 110 | 89 | $0.75 | $82.47 |
| 11302 Removal or Shaving of Skin Growth | Office | 99 | 79 | $80.60 | $7,980 |
| 11102 Skin Biopsy | Office | 92 | 88 | $44.10 | $4,058 |
| 11311 Removal or Shaving of Skin Growth | Office | 86 | 66 | $75.42 | $6,486 |
| 11310 Removal or Shaving of Skin Growth | Office | 81 | 73 | $56.12 | $4,546 |
| 11900 Skin | Office | 64 | 62 | $22.84 | $1,462 |
| 99215 Office E&M - Established | Office | 64 | 57 | $124.09 | $7,942 |
| 99213 Office E&M - Established | Office | 63 | 50 | $60.61 | $3,818 |
By year: 2022 $326K for 6,089 services; 2023 $274K for 5,094 services; 2024 $220K for 4,185 services.
Medicare prescription drug claims, 2024
In 2024, the drug Allison M Linquist prescribed most often to Medicare patients was Triamcinolone Acetonide, with 218 prescriptions and refills. In total Allison M Linquist wrote 1,452 Medicare prescriptions that cost $269K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 218 | 265 | 158 | $2,602 |
| Ketoconazole Generic | 132 | 154 | 71 | $3,185 |
| Mupirocin Generic | 107 | 118 | 83 | $990 |
| Minoxidil Generic | 82 | 202 | 37 | $1,254 |
| Azelaic Acid Generic | 64 | 75 | 39 | $6,146 |
| Fluorouracil Generic | 57 | 61 | 47 | $3,498 |
| Valacyclovir Valacyclovir Hcl | 50 | 70 | 21 | $1,110 |
| Azelastine Hcl Generic | 39 | 92 | 23 | $1,122 |
| Clindamycin Phosphate Generic | 38 | 51 | Under 11 | $1,002 |
| Tazarotene Generic | 38 | 39 | 22 | $8,411 |
| Clobetasol Propionate Generic | 36 | 36 | 21 | $2,340 |
| Ciclopirox Ciclopirox Olamine | 34 | 42 | 13 | $2,070 |
| Tretinoin Generic | 33 | 38 | 29 | $2,978 |
| Cephalexin Generic | 27 | 27 | 23 | $302 |
| Imiquimod Generic | 23 | 25 | 18 | $932 |
Brand drugs: 135 claims; generic drugs: 1,317 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Allison M Linquist $871 ($871 in general payments such as food, travel and fees) from 16 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $151.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $151 |
| Genzyme Corporation SNY | 2 | $81.59 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $77.86 |
| Galderma Laboratories, L.P. GALD.SW | 3 | $65.39 |
| Krystal Biotech Inc KRYS | 3 | $58.45 |
| Lilly USA, LLC LLY | 2 | $56.51 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $54.27 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $52.11 |
| Organon LLC OGN | 2 | $50.4 |
| Amgen Inc. AMGN | 2 | $42.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.